(19)
(11) EP 4 824 265 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24901871.4

(22) Date of filing: 13.12.2024
(51) International Patent Classification (IPC): 
C12N 15/62(2006.01)
A61K 47/54(2017.01)
C07J 5/00(2006.01)
C07K 19/00(2006.01)
C12N 15/85(2006.01)
A61K 39/00(2006.01)
A61P 37/06(2006.01)
C07K 14/47(2006.01)
C12N 15/12(2006.01)
C12N 15/87(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 37/06; C07K 14/47; C12N 15/88; A61K 48/0008; C07J 5/0076; C07K 2319/02; C07K 2319/50; C07K 2319/06; C07K 14/62; C12N 9/88; A61K 47/6929; A61K 47/543; A61K 2039/55555; A61K 39/0005; A61K 2039/53; A61K 39/0008; A61K 2039/54; A61K 2039/545; A61K 39/39; A61K 2039/55566
(86) International application number:
PCT/CA2024/051664
(87) International publication number:
WO 2025/123147 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 14.12.2023 US 202363609977 P
14.12.2023 US 202363609983 P

(71) Applicant: Integrated Nanotherapeutics Inc.
Burnaby BC V5G 4X4 (CA)

(72) Inventors:
  • TAM, Yuen Yi
    Burnaby, British Columbia V5G 4X4 (CA)
  • CHEN, Sam
    Burnaby, British Columbia V5G 4X4 (CA)
  • DENROCHE, Heather
    Burnaby, British Columbia V5G 4X4 (CA)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) TOLERIZING IMMUNOMODULATORY COMBINATION